In conclusion, Gsdmd−/− mice showed increased intestinal barrier damage and hepatic LPS stimulation after ConA injection, which may contribute to the aggravation of Gsdmd deficiency to ConA-induced hepatitis. The gene discussed is GSDMD; the disease is hepatitis A virus infection.